Jong Woo Lee, PhD is a Research Scientist at the Yale Cancer Center and Yale University School of Medicine. He has expertise on numerous innovative techniques covering cancer biology, pharmacology, metabolism and in vivo preclinical evaluation of therapeutics including targeted therapy and immuno-oncology.

Mar 30, 2022 · She and her collaborator, Jong Woo Lee, PhD, a research scientist at Yale Cancer Center, recently presented their striking findings. Non-small cell lung cancer (NSCLC) with KRAS mutation accounts for about 30 percent of all lung cancers.

Jong Woo LEE, Associate Research Scientist | Cited by 1,205 | of Yale University, CT (YU) | Read 39 publications | Contact Jong Woo LEE

Mar 22, 2024 · Regulation of autophagy to optimize AURKA inhibition-mediated therapeutics in head and neck cancer (Jong Woo Lee)

Yale School of Medicine. MENU

ICASSP 2020-2020 IEEE International Conference on Acoustics, Speech and …

Jong Woo Lee, PhD, will present study findings with @BarbaraBurtness on AURKA inhibition in KRAS-mutated #lungcancer at the @IASLC 2022 World Conference on Lung Cancer, Sunday, 8/7 at 11:12am EST. https://bit.ly/3QdexGe @SmilowCancer @YNHH …

Jung Woo Lee via Scopus - Elsevier Weight Change Is Associated with Osteoporosis: A Cross Sectional Study Using the Korean Community Health Survey International Journal of Environmental Research and Public Health